Bridging Two Worlds of Knowledge
For millennia, human cultures across the globe have cultivated a deep, empirical understanding of psychoactive plants, using them in sacred rituals, healing ceremonies, and rites of passage. This vast repository of ethnobotanical wisdom, often preserved through oral tradition, represents an invaluable lead-generating library for modern psychotropic biology. The Institute approaches this knowledge not as folklore to be mined, but as a parallel and complementary scientific tradition. Our Ethnobotany and Systems Biology division works to translate the holistic insights of traditional use into the rigorous, reductionist language of modern science, creating a powerful feedback loop where each paradigm informs and validates the other.
From Ceremony to Chromatography
The first step is rigorous phytochemical analysis. Plants like *Psilocybe* mushrooms, *Banisteriopsis caapi* (ayahuasca vine), *Tabernanthe iboga*, and *Salvia divinorum* are complex matrices containing hundreds of bioactive compounds. Using advanced techniques like high-performance liquid chromatography coupled with mass spectrometry (HPLC-MS) and nuclear magnetic resonance (NMR) spectroscopy, we isolate and identify not just the primary known alkaloids (psilocybin, DMT, ibogaine, salvinorin A) but also the 'entourage' of secondary metabolites. Traditional preparations often involve specific combinations of plants (like the MAO-inhibiting vine with DMT-containing leaves in ayahuasca) or precise preparation methods (fermentation, heating, sequential extraction). Our lab recreates these methods to understand the pharmacologically sophisticated reasoning behind them, often finding that these traditional practices optimize bioavailability, modulate effects, or mitigate toxicity.
Systems Biology and the Polypharmacology Hypothesis
Modern pharmacology often seeks a single, pure, molecular target—the 'magic bullet.' Traditional plant medicines, however, are inherently 'shotgun' therapies. Systems biology provides the perfect framework to understand this. Instead of looking at one receptor in isolation, we use computational models to map how the entire cocktail of plant compounds interacts with the human 'interactome'—the complete network of proteins, genes, and metabolites in the body. We hypothesize that the profound and often holistic healing reported from traditional use arises from this polypharmacology: simultaneous, synergistic action on multiple neural, immunological, and endocrine systems. For example, an ayahuasca brew may simultaneously modulate serotonin receptors (via DMT), alter gut microbiome and monoamine metabolism (via harmala alkaloids), and induce an anti-inflammatory cascade through other, yet-unknown plant constituents, addressing mental, physical, and spiritual dimensions of distress in an interconnected way.
Reciprocity and Collaborative Research
This work is conducted under principles of reciprocity and collaboration. The Institute partners directly with indigenous councils and traditional healers, ensuring they are recognized as intellectual contributors and share in the benefits of any commercial developments derived from their knowledge. Joint research projects might involve traditional healers working alongside our chemists to select specific plant specimens for study based on their nuanced understanding of plant energetics and potency, which often correlates with measurable chemical differences. Furthermore, we study the ritualistic and set-and-setting aspects of traditional use as active therapeutic components, integrating these psychosocial elements into our clinical models. This integrative approach honors the depth of traditional wisdom while subjecting it to the validating scrutiny of the scientific method, promising not only new drug discoveries but a more holistic, culturally informed, and effective paradigm for psychotropic healing.